Publications
Genentech scientists are encouraged to be creative and active members of the scientific community. We are proud of our publication record in Science, Nature, Cell, and other prestigious peer-reviewed journals, where our annual output consistently rivals or surpasses that of the top academic institutions.
|
British Journal of Pharmacology, ISSN: 14765381 00071188
|
|
Current nonclinical testing paradigm enables safe entry to First-In-Human clinical trials: The IQ consortium nonclinical to clinical translational database
Toxicology and Applied Pharmacology, ISSN: 0041008X
|
|
Pharmacopeial Forum, ISSN: 15421945 03634655
|
|
Nature, ISSN: 14764687 00280836
|
|
The Integumentary System
Fundamentals of Toxicologic Pathology: Third Edition,
|
|
Journal of Gastrointestinal Cancer, ISSN: 19416636 19416628
|
|
Organic Process Research and Development, ISSN: 1520586X 10836160
|
|
Bioconjugate Chemistry, ISSN: 15204812 10431802
|
|
Proceedings of the National Academy of Sciences of the United States of America, ISSN: 10916490 00278424
|
|
Cancer Chemotherapy and Pharmacology, ISSN: 14320843 03445704
|
|
Cancer Research, ISSN: 15387445 00085472
|
|
Bioinformatics, ISSN: 14602059 13674803
|
|
Journal of Medicinal Chemistry, ISSN: 15204804 00222623
|
|
ACS Medicinal Chemistry Letters, ISSN: 19485875
|
|
New England Journal of Medicine, ISSN: 15334406 00284793
|
|
Cancer Chemotherapy and Pharmacology, ISSN: 14320843 03445704
|
|
Protein and Cell, ISSN: 16748018 1674800X
|
|
Nature Structural and Molecular Biology, ISSN: 15459985 15459993
|
|
Molecular Pharmaceutics, ISSN: 15438392 15438384
|
|
Bioanalysis, ISSN: 17576199 17576180
|
|
Retina, ISSN: 15392864 0275004X
|
|
Drug Discovery Today, ISSN: 18785832 13596446
|
|
Protein Science, ISSN: 1469896X 09618368
|
|
Advances in Therapy, ISSN: 18658652 0741238X
|
|
Nature Genetics, ISSN: 15461718 10614036
|
|
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors
PLoS ONE, ISSN: 19326203
|
|
EMBO Reports, ISSN: 14693178 1469221X
|
|
European Journal of Immunology, ISSN: 15214141 00142980
|
|
Clinical Immunology, ISSN: 15217035 15216616
|
|
CYP1A1-mediated intramolecular rearrangement of aminoazepane in GDC-0339
Drug Metabolism and Disposition, ISSN: 00909556
|
|
Pulmonary Pharmacology and Therapeutics, ISSN: 15229629 10945539
|
|
Physiological Reviews, ISSN: 15221210 00319333
|
|
Experimental Biology and Medicine, ISSN: 15353699 15353702
|
|
Haematologica, ISSN: 15928721 03906078
|
|
Ubiquilin1 promotes antigen-receptor mediated proliferation by eliminating mislocalized mitochondrial proteins
eLife,
|
|
Xenobiotica, ISSN: 13665928 00498254
|
|
Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animals
mAbs, ISSN: 19420862
|
|
Photodegradation Pathways of Protein Disulfides: Human Growth Hormone
Pharmaceutical Research, ISSN: 07248741
|
|
Platform model describing pharmacokinetic properties of vc-MMAE antibody–drug conjugates
Journal of Pharmacokinetics and Pharmacodynamics, ISSN: 1567567X
|
|
Asymmetric Synthesis of Akt Kinase Inhibitor Ipatasertib
Organic Letters, ISSN: 15237060
|
|
Kumada-Corriu Heteroaryl Cross-Coupling for Synthesis of a Pharmaceutical Intermediate: Comparison of Batch Versus Continuous Reaction Modes
Organic Process Research and Development, ISSN: 10836160
|
|
Pirfenidone reduces respiratory-related hospitalizations in idiopathic pulmonary fibrosis
American Journal of Respiratory and Critical Care Medicine, ISSN: 1073449X
|
|
Single-cell dynamics determines response to CDK4/6 inhibition in triple-negative breast cancer
Clinical Cancer Research, ISSN: 10780432
|
|
Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral Angles
ACS Medicinal Chemistry Letters,
|
|
Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eye
mAbs, ISSN: 19420862
|
|
Randomized phase III trial of trastuzumab plus capecitabine with or without pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who experienced disease progression during or after trastuzumab-based therapy
Journal of Clinical Oncology, ISSN: 0732183X
|
|
Journal of the American Chemical Society, ISSN: 15205126 00027863
|
|
Autophagy, ISSN: 15548635 15548627
|
|
Lung Cancer, ISSN: 18728332 01695002
|
|
RMD Open, ISSN: 20565933
|
